| 臨床腫瘍医学講座 | |||||||
| Department of Medical Oncology | |||||||
| 整理番号 | 論文の 種類 |
著者名 | タイトル | 雑誌名 書名 外 |
巻（号） | ページ | 年号 |
| 0862001 | 総説 | 高張大亮,白尾国昭. | 消化管癌に対する科学療法の進歩 消化器. | Annual Review 消化器 2008,中外医学社.東京 | 67-74, | 2008. | |
| 0862002 | その他 | 白尾国昭,朴成和. | 切除不能・再発胃癌に対する5-FU vs CPT-11+CDDP vs S-の第Ⅲ相試験(JCOG9912). | 胃癌化学療法をめぐる最新の学術情報 | 2008. | ||
| 0862003 | ｐｒｏｃｅｅｄｉｎｇ | 白尾国昭. | 切除不能・再発胃癌に対する 5-FU vs.CPT-11＋CDDP vs.S-1の第Ⅲ相試験(JCOG9912). | The 45th Annual Meeting of Japan Society of Clinical Oncology | 2008. | ||
| 0862004 | 総説 | 渡邉浩一郎,白尾国昭. | .薬剤師のための臨床講座―胃がん化学療法の進歩. | Pharmavision | 12 (3), | 2-8, | 2008. |
| 0862005 | 総説 | 平島詳典，白尾国昭. | 胃癌―基礎・臨床研究のアップデートーⅨ．治療―現状・動向・評価―進行中の大規模臨床試験の概要. | 日本臨牀社 | 66 (5), | 2008. | |
| 0862006 | 総説 | 大津智,白尾国昭. | 分子標的治療薬の臨床試験の現状と課題. | Frontiers in Gastroenterology | 13 (3), | 2008. | |
| 0862007 | 総説 | 渡邉浩一郎、白尾國昭. | 大腸癌化学療法の実際 ファーストライン－どう選び、どう行うか。FOLFIRI. | 消化器の臨床 | 11 (5), | 499-505, | 2008. |
| 0862008 | 原著 | Sai k,saito Y,itoda M,Fukushima-Uesaka H,Nishimaki-mogami
T,Ozawa s,Maekawa k,Kurosw k,kamiwa N,Kawamoto M,Shirao K,Hamaguchi
T,Yamamoto N,Kunitoh H,Ohe Y,Yamada Y,Tarura T,Yoshida T,Minami H,Matsumura
Y,Ohtsu A,saijo N,and Sawada J. |
Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. | Drug Metab Pharmacokinet | 23 (2), | 139-47, | 2008. |
| 0862009 | 原著 | Matsubara J, Nishina T, Yamada Y, Moriwaki T, Shimoda T,
Kajiwara T, Nakajima TE, Kato K, Hamaguchi T, Shimada Y, Okayama Y, Oka T,
Shirao K. |
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. | BRIT J CANCER | 98 (4), | 832-839, | 2008. |
| 0862010 | 原著 | Sai K,Saito Y,Sakamoto H,Shirao K,Kurose K, Saeki M, Ozawa S,
Kaniwa N, Hirohashi S, Saijo N, Sawada J,Yoshida T. |
Importance of UDP-glucuronosyltransferase 1A1* 6 foririnotecan toxicities in Japanese cancer patients. | CANSER Letters | 261 | 165-171 | 2008. |
| 0862011 | 原著 | Nakajima T, Yamada Y, Shimoda T, Matsubara J, Kato K, Hamaguchi T, Shimada Y, Okayama Y, Oka T, Shirao K. | Combination of O(6)-methylguanine-DNA methyltransferase and thymidylate synthase for the prediction of fluoropyrimidine efficacy. | EUR J CANCER | 44 (3), | 400-407, | 2008. |
| 0862012 | 原著 | Nakajima T, Yasunaga M, Kano Y, Koizumi F, Kato K, Hamaguchi T,
Yamada Y, Shirao K, Shimada Y, Matsumura Y. |
Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil. | INT J CANCER | 122 (9), | 2148-2153, | 2008. |
| 0862013 | 原著 | Nishida T,Shirao K, Sawaki A,Koseki M,Okamura T,Ohtsu A, Sugiyama T,Miyakawa T,Hirota S. | Efficacy and safety profile of imatinib mesylate (ST1571) in
Japanese patients with advanced gastrointestinal stromal tumors: a phase II
study (STI571B1202). . |
Int J Clin Oncol | 13 | 244-251, | 2008. |
| 0862014 | 原著 | Matsubara J, Yamada Y, Hirashima Y, Takahari D, Okita NT, Kato
K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T. |
Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer. | Clin Cancer Res | 14 (10), | 3022-3029, | 2008. |
| 0862015 | 原著 | Yasuo Shima, Atshushi Ohtsu, Kuniaki Shirao, Yasutsuna Sasaki. | Clinical Efficacy
and Safety of Octreotide (SMS201-995) in Terminally Ill Japanese Cancer
Patients with Malignant Bowel Obstruction. |
Jpn J Clin Oncol | 38 （5）, | 354 - 359. | 2008. |
| 0862016 | 原著 | Hamaguchi T, Shirao K, Yamamichi N, Hyodo I, Koizumi W, Seki S,
Imamura T, Honma H, Ohtsu A, Boku N, Mukai T, Yamamoto S, Fukuda H, Yoshida
S,Gastrointestinal Oncology Study Group of Japan Clinical Oncology
Group. |
A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial. | Jpn J Clin Oncol | 38 （6） | 432-437, | 2008. |
| 0862017 | 原著 | Yamada Y, Tahara M, Miya T, Satoh T, Shirao K, Shimada Y, Ohtsu
A, Sasaki Y, Tanigawara Y. |
Phase I/II study of oxaliplatin with oral S-1 as first-line therapy for patients with metastatic colorectal cancer. | Br J Cancer | 98 (6), | 1034-8, | 2008. |
| 0862018 | 原著 | Matsubara J, Yamada Y, Nakajima TE, Kato K, Hamaguchi T, Shirao
K, Shimada Y, Shimoda T. |
Clinical Significance of Insulin-Like Growth Factor Type 1 Receptor and Epidermal Growth Factor Receptor in Patients with Advanced Gastric Cancer. | Oncology | 74 (1-2), | 76-83, | 2008. |
| 0862019 | 原著 | Ymada Y,Arao T, Gotoba T,Taniguchi H,Oda I, Shirao K, Shimada T,
HAmaguchi T, Kato K, Hamano T,
Koizumi F,Tamura T, Saito D, Shimoda T, Saka M, Fukagawa T, Katai H, Sano T,
Sasako,and M Nishio K. |
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. | Cancer sci | 99 (11), | 2193-9, | 2008. |
| 0862020 | 原著 | Matsubara J, Shimada Y, Takashima A, Takahari D, Hirashima Y,
Okita NT, Nakajima TE, Kato K, Hamaguchi T, Yamada Y, Shirao K. |
A phase Ｉ study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer. | Jpn J Clin Oncol | 38 (8), | 540-6, | 2008. |
| 0862021 | 原著 | Takashima A, Shirao K, Hirashima Y, Takahari D, Okita N,
Akatsuka S, Nakajima TE, Matsubara J, Yasui H, Asakawa T, Kato K, Hamguchi T,
Muro K, Yamada Y, Shimada Y. |
Chemosensitivity of patients with recurrent esophageal cancer receiving perioperative chemotherapy. | Diseases of the Esophagus | 21 | 607-611 | 2008. |
| 0862022 | 原著 | Tahara M, Shirao K, Boku N, Yamaguchi K, Komatsu Y, Inaba Y,
Arai T, Mizunuma N, Satoh T, Takiuchi H, Nishina T, Sakata Y. |
Multicenter Phase II study of cetuximab plus irinotecan in
metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin and
fluoropyrimidines. |
Jpn J Clin Oncol | 38 (11), | 762-9, | 2008. |
| 0862023 | 原著 | Ono M, Shirao K, Takashima A,Morizane C,Okita N, Takahari D,
Hirashima Y,Nakajima R, Kato K, Hamaguchi T, Yamada Y,Yasuhiro Shimada. |
Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine. | Gastric Cancer | 11 | 201-205, | 2008. |
| 0862024 | 原著 | Saito Y, Sai K, Maekawa K, Kaniwa N, Shirao K, Hamaguchi T,
Yamamoto N, Kunitoh H, Ohe Y, Yamada Y, Tamura T, Yoshida T, Minami H, Ohtsu
A, Matsumura Y, Saijo N, Sawada JI. |
Close Association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6 or *60 Haplotype and its Apparent Influence on SN-38 Glucuronidation in Japanese. | Drug Metab Dispos | 37 (2), | 272-6, | 2008. |
| 0862025 | 症例報告 | 白尾国昭（分担執筆）. | がん 最良の治療選択―ベストの治療法が必ず見つかる. | 渡辺 亨, 株式会社エビデンス社,東京 |
2008. | ||
| 0862026 | その他 | 白尾国昭. | 第８０回日本胃癌学会「S-1＋CDDPが浮上、進行胃がんの標準的First-Line化学療法Ｓecond-Line化学療法の６臨床試験が指導」. |
Medical Tribune | 41 (15), | 14-15, | 2008. |
| 0862027 | その他 | 白尾国昭. | 「イリノテカン・オキサリプラチンの主要臨床試験成績文献要約集」. | ヤクルト本社 | 2008. | ||
| 0862028 | その他 | 白尾國昭（監修）. | 胃癌化学療法のＮew Phase ―最新のエビデンスを臨床に活かす―. | 、第一三共株式会社トポテシン学術資材 | 2008. | ||
| 0862029 | その他 | 白尾國昭（監修）. | 、カンプトの治療をうけられる皆さまへー薬の解説と治療中のアドバイス（FOLFIRI療法）. |
株式会社ヤクルト本社,リノ・メディカル株式会社 | 2008. | ||
| 0862030 | 原著 | 石岡千加史、西条康夫、佐々木康綱、白尾国昭、柳原一広、矢野聖二、吉岡孝志. |
大学腫瘍内科のあり方. | Jpn J Caemother | 5 (6), | 1044-1052, | 2008. |
| 0862031 | その他 | 白尾國昭、井上忠夫、関野礼子. | がんチーム医療を支えるコメディカルの役割―医師、薬剤師、看護師それぞれの立場からみた現状と今後の展望―. |
unite,ヤクルト本社 | 創刊準備号 | 2008. | |
| 0862032 | その他 | 白尾國昭（編集委員）. | Ｕnite(ユニテ)―がん治療を支えるコメディカルのための情報誌―. | エルゼビアジャパン株式会社 | 創刊号 (1), | 2008. | |
| 0862033 | その他 | 白尾國昭. | 腫瘍内科新任教授に聞く. | The medical Oncologists, ターギス株式会社 | 13 (4), | 11-13, | 2008. |
| 0862034 | 総説 | 森永亮太郎、白尾國昭. | 国外大規模臨床試験（REAL－２試験）の結果とわが国の胃がん診療にもたらす影響－特集ー国外大規模臨床試験の意義と国内がん診療へのインパクト. |
月刊 血液・腫瘍内科 | 57 （5）, | 524－530, | 2008. |
| 0862035 | その他 | 白尾國昭（編集委員）. | Ｕnite(ユニテ)―がん治療を支えるコメディカルのための情報誌―. | エルゼビアジャパン株式会社 | 2 | 2008. | |
| 0862036 | その他 | 白尾國昭. | 大腸がんー医療最前線ー. | 新聞赤旗（日曜版）,日本共産党中央委員会 | 2008年12月7日号 （32）, | 2008. | |
| 0862037 | 原著 | Watanabe K, Rao VP, Poutahidis T, Rickman BH, Ohtani M, Xu S,
Rogers AB, Ge Z, Horwitz BH, Fujioka T, Erdman SE, Fox JG. |
CTLA-4 blockade
abrogates protection by regulatory T cells in a mouse model of
microbially-induced innate immune-driven colitis. |
Infect Immun | 76 (12), | 5834-42, | 2008. |
| 0862038 | 原著 | Poutahidis T, Haigis KM, Rao VP, Nambiar PR, Taylor CL, Ge Z,
Watanabe K, Davidson A, Horwitz BH, Fox JG, Erdman SE. |
Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. | Carcinogenesis | 28 (12), | 2614-23, | 2008. |
| 0862039 | 症例報告 | Umeki K, Ishii H, Yoshikawa H, Morinaga R, Kishi K, Shirai R,
Tokimatsu I, Hiramatsu K, Kadota J. |
[A case of amyopathic dermatomyositis-associated interstitial pneumonia accompanied with massive hemothorax]. | Nihon Kokyuki Gakkai Zasshi | 46(11) | 940-4, | 2008. |
| 0862040 | 原著 | Morinaga R, Okamoto I, Fujita Y, Arao T, Sekijima M, Nishio K,
Ito H, Fukuoka M, Kadota JI, Nakagawa K. |
Association of epidermal growth factor receptor (EGFR) gene
mutations with EGFR amplification in advanced non-small cell lung
cancer. |
Cancer Sci | 99 (12), | 2455-60, | 2008. |
| 0862041 | 原著 | Miyajima Y, Hiramatsu K, Mizukami E, Morinaga R, Ishii H, Shirai
R, Kishi K, Tokimatsu I, Saikawa T, Kadota J. |
In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa. | Int J Antimicrob Agents | 32 (5), | 437-40, | 2008. |
| 0862042 | 症例報告 | Hisamatsu Y, Ishii H, Kai N, Amemiya Y, Otani S, Morinaga R,
Shirai R, Umeki K, Kishi K, Tokimatsu I, Hiramatsu K, Kadota J. |
Case of toxocariasis showing migratory nodular shadows with halos. | Nihon Kokyuki Gakkai Zasshi | 46 (5), | 420-4, | 2008. |
| 0862043 | 症例報告 | Kai N, Ishii H, Iwata A, Umeki K, Shirai R, Morinaga R, Kishi K,
Tokimatsu I, Hiramatsu K, Yamagata E, Kadota J. |
Chronic hypersensitivity pneumonitis induced by Shiitake mushroom cultivation: case report and review of literature. | Nihon Kokyuki Gakkai Zasshi | 46 (5), | 411-5, | 2008. |
| 0862044 | 症例報告 | Otani S, Ishii H, Hashinaga K, Morinaga R, Umeki K, Kishi K,
Shirai R, Tokimatsu I, Hiramatsu K, Kawahar K, Kadota J. |
Pulmonary metastasis of fibrosarcomatous variant of dermatofibrosarcoma protuberans: case report and review of literature. | Nihon Kokyuki Gakkai Zasshi | 46(3) | 253-7 | 2008. |
| 0862045 | 著書 | 森永亮太郎、門田淳一. |
胸水貯蓄―生涯教育シリーズ７５－呼吸器疾患診療マニュアル. | 日本医師会雑誌.日本医師会 | 137 （2）, | 86－87, | 2008. |
| 0862046 | 総説 | 平島詳典,山田康秀. | 術後補助化学療法の適応となる症例. | オンコロジストはこう治療している 胃がん診療と化学療法. ヴァンメディカル | 2, | 51-52, | 2008. |
| 0862047 | 総説 | 平島詳典,山田康秀. | 術後補助療法の適応となる症例. | オンコロジストはこう治療している 胃がん診療と化学療法.ヴァンメディカル |
2, | 53-56 | 2008. |
| 0862048 | 原著 | Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F,
Mimori K, Kamohara Y, Inoue H, Mori M. |
CD133+CD44+ population efficiently enriches colon cancer initiating cells. | Ann Surg Oncol | 15(10) | 2927-33, | 2008. |
| 0862049 | 原著 | Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M, Yokobori
T, Hirasaki S, Takatsuno Y, Sakashita H, Ishii H, Sasako M, Mori M. |
A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. | gastric cancer cases | 15 (10), | 2934-42, | 2008. |
| 0862050 | 原著 | .Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K,
Matsumoto T, Inoue H, Kuwano H, Mori M. |
Biological and genetic characteristics of tumor-initiating cells in colon cancer. | Ann Surg Oncol | 15 (2), | 638-48, | 2008. |